AL SB239 | 2023 | Regular Session
Status
Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on May 18 2023 - 100% progression
Action: 2023-05-18 - Enacted
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on May 18 2023 - 100% progression
Action: 2023-05-18 - Enacted
Text: Latest bill text (Enrolled) [PDF]
Summary
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Title
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Sponsors
Roll Calls
2023-05-18 - House - Read a Third Time and Pass (Y: 102 N: 0 NV: 0 Abs: 3) [PASS]
History
Date | Chamber | Action |
---|---|---|
2023-05-18 | Senate | Enacted |
2023-05-18 | Senate | Enrolled |
2023-05-18 | House | Ready to Enroll |
2023-05-18 | House | Read a Third Time and Pass |
2023-05-18 | House | On Third Reading in Second House |
2023-05-11 | House | Read Second Time in Second House |
2023-05-10 | House | Reported Out of Committee in Second House |
2023-05-10 | House | Reported Favorably from House Health |
2023-05-04 | House | Referred to Committee to House Health |
2023-05-04 | Senate | Read First Time in Second House |
2023-05-03 | Senate | Read a Third Time and Pass |
2023-05-03 | Senate | Read a Third Time and Pass |
2023-05-03 | Senate | On Third Reading in House of Origin |
2023-04-27 | Senate | Read Second Time in House of Origin |
2023-04-26 | Senate | Reported Out of Committee in House of Origin |
2023-04-26 | Senate | Reported Favorably from Senate Healthcare |
2023-04-25 | Senate | Introduced and Referred to Senate Healthcare |
2023-04-25 | Senate | Read First Time in House of Origin |